Share
𝕏 Facebook LinkedIn

Low frequency electromagnetic field decreases ischemia-reperfusion injury of human cardiomyocytes and supports their metabolic function.

PAPER pubmed Experimental biology and medicine (Maywood, N.J.) 2018 In vitro study Effect: benefit Evidence: Low

Abstract

Electromagnetic field at extremely low frequencies plays a significant role in the physiological function of human tissues and systems. It is shown that electromagnetic field inhibits production of reactive oxygen species which are involved in heart injury triggered by oxidative stress. We hypothesize that low frequency electromagnetic field protects function of cardiac cells from ischemia-reperfusion injury. Human cardiac myocytes, endothelial cells, and cardiac fibroblast underwent ischemia-reperfusion conditions in the presence or in the absence of low frequency electromagnetic field. LDH and MMP-2 activities (as markers of cell injury), and cell metabolic activity (by fluorescein diacetate staining) were measured to determine the protective role of low frequency electromagnetic field. Our data showed that short courses of low frequency electromagnetic field protect cardiac cells from cellular damage and preserve their metabolic activity during ischemia-reperfusion. This study demonstrates the possibility to use of low frequency electromagnetic field as strategy for the prevention or therapy of ischemia-reperfusion injury. Impact statement In our study, we showed that LF-EMF may be protective for heart during ischemia-reperfusion (I/R). Following is the short description of the main findings: (a) the response to the I/R injury was different for endothelial cells, fibroblasts, and cardiomyocytes; (b) I/R decreases MMP-2 activity in cardiac myocytes and fibroblasts;

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
benefit
Population
Human cardiac myocytes, endothelial cells, and cardiac fibroblasts (cell culture)
Sample size
—
Exposure
ELF · short courses (duration not specified)
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

Under ischemia-reperfusion conditions, short courses of low frequency electromagnetic field exposure were associated with reduced cellular damage and preserved metabolic activity in human cardiac cells. The abstract notes that responses differed across endothelial cells, fibroblasts, and cardiomyocytes, and that ischemia-reperfusion decreased MMP-2 activity in cardiac myocytes and fibroblasts.

Outcomes measured

  • Ischemia-reperfusion cell injury (LDH activity)
  • MMP-2 activity
  • Cell metabolic activity (fluorescein diacetate staining)
  • Reactive oxygen species production (mentioned as inhibited; measurement not described)

Limitations

  • No exposure parameters reported (frequency, field strength, waveform, exposure setup).
  • No sample size or replication details provided in the abstract.
  • Results are from in vitro human cells; clinical relevance is not established in the abstract.
  • Details on ROS measurement are not provided (only stated as inhibited).
View raw extracted JSON
{
    "study_type": "in_vitro",
    "exposure": {
        "band": "ELF",
        "source": null,
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "short courses (duration not specified)"
    },
    "population": "Human cardiac myocytes, endothelial cells, and cardiac fibroblasts (cell culture)",
    "sample_size": null,
    "outcomes": [
        "Ischemia-reperfusion cell injury (LDH activity)",
        "MMP-2 activity",
        "Cell metabolic activity (fluorescein diacetate staining)",
        "Reactive oxygen species production (mentioned as inhibited; measurement not described)"
    ],
    "main_findings": "Under ischemia-reperfusion conditions, short courses of low frequency electromagnetic field exposure were associated with reduced cellular damage and preserved metabolic activity in human cardiac cells. The abstract notes that responses differed across endothelial cells, fibroblasts, and cardiomyocytes, and that ischemia-reperfusion decreased MMP-2 activity in cardiac myocytes and fibroblasts.",
    "effect_direction": "benefit",
    "limitations": [
        "No exposure parameters reported (frequency, field strength, waveform, exposure setup).",
        "No sample size or replication details provided in the abstract.",
        "Results are from in vitro human cells; clinical relevance is not established in the abstract.",
        "Details on ROS measurement are not provided (only stated as inhibited)."
    ],
    "evidence_strength": "low",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "extremely low frequency",
        "low frequency electromagnetic field",
        "ELF-EMF",
        "ischemia-reperfusion",
        "cardiomyocytes",
        "endothelial cells",
        "cardiac fibroblasts",
        "LDH",
        "MMP-2",
        "metabolic activity",
        "oxidative stress"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.